Pharmacy management company CarepathRx to acquire Chartwell from UPMC for $400 million

PITTSBURGH — CarepathRx, a Seattle-based pharmacy management company, announced its plans to acquire the specialty pharmacy operations of Chartwell, a UPMC subsidiary, in a deal valued at $400 million. UPMC will become a strategic investor in CarepathRx as part of the acquisition.

“Our partnership with UPMC and Chartwell is an important step for CarepathRx,” CarepathRx CEO and founder John Figueroa said in a press release. “We set out to create a new approach to pharmacy care in the market—one that is centered on the patient and that works collaboratively with both the provider and the payor of health care. We welcome the team at Chartwell to the CarepathRx family and are thrilled to partner with UPMC to help us achieve our mission.”

The transaction is expected to close within 30 days and Cantor Fitzgerald & Co. will serve as the financial advisor to Chartwell as it transitions to CarepathRx’s management.

Read more from out news partners at the Pittsburgh Business Times.

Local hospitals prepared for increase of COVID-19 cases

Pittsburgh Business Times